Submaximal test PWC -170. TEST NAVAKI Harvard step test the study makes climbing a step height of 50...

Post on 19-Dec-2015

226 views 0 download

Tags:

transcript

Submaximal test PWC -170Submaximal test PWC -170

TEST NAVAKITEST NAVAKI

Harvard step testHarvard step test

the study makes climbing a step height of 50 cm the study makes climbing a step height of 50 cm for menfor men

height of 43 cm for womenheight of 43 cm for women

Evaluation of the sample.Evaluation of the sample.

Upon completion of the subject sample sits Upon completion of the subject sample sits sitting and resting. He counted heart rate sitting and resting. He counted heart rate during the first 30 s 2, 3, 4-minute recovery during the first 30 s 2, 3, 4-minute recovery period. Test results are substituted in the period. Test results are substituted in the equation:equation:

t x 100 IHST = (f1 + f2 + f3) x t x 100 IHST = (f1 + f2 + f3) x 22

where IHST - index Harvard step test, t - where IHST - index Harvard step test, t - climbing a step in the desired tempo in climbing a step in the desired tempo in seconds (when fully implemented 5 minute seconds (when fully implemented 5 minute load is 300 s), f1, f2, f3 - heart rate during the load is 300 s), f1, f2, f3 - heart rate during the first 30 s by 2, 3, 4 minutes into the recovery first 30 s by 2, 3, 4 minutes into the recovery period.period.

Evaluation of the Harvard step testEvaluation of the Harvard step test

Assessment of physical fitness Assessment of physical fitness

Less than 55 bad Less than 55 bad

                          55-64 Below Average 55-64 Below Average

                          65-79 average 65-79 average

                        80-89 Good 80-89 Good

                        90 or more distinctive90 or more distinctive

Test NavakiTest Navaki

Direct determination of MSCsDirect determination of MSCs

Test KuperTest Kuper

Medical group

criteria for appointment Physical load State of

health Physical development

Features

Basic Virtually healthy or with minor deviations in health

Appropriate to the age, sex

Appropriate to the age, sex

Involved in programs approved for schools. Visit the sports section. Take part in competitions

Medical groups for physical education

Preparation Virtually healthy

or with minor disabilities health status

reduced reduced Studying at the same programs. Attend more classes. Let standards in later terms

Special Variations in state health permanent or temporary nature that require restriction physical load admitted to performance educational and production activities

reduced reduced Engaged in special programs. Exemption from putting some standards

Name of group Medical characteristics of the group Recommended occupations

1 2 3

First- І Those middle-aged and elderly without variations in health status with sufficient physical training

Classes in groups PFD "Health" for special programs compete according to age

Second - ІІ Those middle-aged and elderly with minor deviations in health status in the background age-related changes, but without significant functional impairment

Classes in groups PFD "Health" special programs for ages

Third-ІІІ Those middle and old age with disabilities in health permanent or temporary nature, against age-related changes in functional impairment, without sufficient preparation

Sports physical therapy following the procedure developed for patients with various diseases.

Medical groups for physical education of middle and old age.

Quantitative dosage of physical activity:

1.For relative power.

2.For metabolic parameters.

3.For heart rate

4.The empirical method.

5.As the number of repetitions of exercise.

Dosage of physical activity:

1. intensity

2. For on the "volume of work performed

3. By the time training

4. In the interval between sessions

5. Nature of rest between sessions

Signs of fatigue:

Level of fatigue:

inconsiderable

Significant (mean)

Sharp (high)

Color of skin minor flushed

Significant flushed

Sharp flushing, pallor, cyanosis

Sweating Not high high Very high

External signs of fatigue:

Breathing Often, equal Very often Sharp pochaschene, shallow breathing mouth, shortness of breath

Coordination of movements

Cheerful procession

Unbalanced gait, staggering body

The sharp rocking body, uncoordinated movements

Attention Fulfilling unmistakable indications

Uncertainty execution of the

Inhibited fulfilling the commands are executed only vowel team

Wellbeing No complaints

Complaints of fatigue, leg pain, palpitations, shortness of breath

Complaints of fatigue, leg pain, palpitations, shortness of breath, headache, dizziness

0

50

100

150

200

250

ЧСС 1

ЧСС 2

ЧСС 3

ЧСС 4

:Physiological curves trainings, reflecting different degrees of effect on the body and scheme of studies

1 small effect; 2 significant impact; 3 very sharp start training; 4th absence of the final part.

Physical factors.Physical factors.

Baths can be used as a Russian bath with steam room unit where the Baths can be used as a Russian bath with steam room unit where the temperature is maintained air 45 - 600 s, relative humidity of 75 - 100% temperature is maintained air 45 - 600 s, relative humidity of 75 - 100% and Dry-air (usually Finnish (sauna), where the air temperature is 70 - and Dry-air (usually Finnish (sauna), where the air temperature is 70 -

900S humidity 10 - 25% ).900S humidity 10 - 25% ).

Massage in sports medicine are divided into Massage in sports medicine are divided into preparatory (mobilizing), restorative, preparatory (mobilizing), restorative,

preventive, rehabilitativepreventive, rehabilitative..

For details of the IOC Doping include 5 For details of the IOC Doping include 5 groups of pharmacological agents :groups of pharmacological agents :

· Psycho-stimulant drugs ( amphetamine, · Psycho-stimulant drugs ( amphetamine, fennetrazyn et al. ). These compounds act fennetrazyn et al. ). These compounds act primarily on mental health by strengthening primarily on mental health by strengthening the processes of excitation , no fatigue ;the processes of excitation , no fatigue ;

· Sympathomimetic amino substances · Sympathomimetic amino substances ( ephedrine, metoksyfenamin ), acting ( ephedrine, metoksyfenamin ), acting through the autonomic nervous centers the through the autonomic nervous centers the scope of the body , increasing blood scope of the body , increasing blood circulation, respiratory system and the circulation, respiratory system and the activities of others;activities of others;

· Stimulants of the central nervous system · Stimulants of the central nervous system ( nuketomid , koramin , strychnine , etc. );( nuketomid , koramin , strychnine , etc. );

· Drugs and substances that relieve pain · Drugs and substances that relieve pain (morphine, codeine , etc. );(morphine, codeine , etc. );

· Anabolic Steroids ( nerabol , retabolil , · Anabolic Steroids ( nerabol , retabolil , etc.).etc.).

PROHIBITED SUBSTANCES? S1. Anabolic agents Use of anabolic agents is PROHIBITED SUBSTANCES? S1. Anabolic agents Use of anabolic agents is prohibited. 1. Anabolic androgenic steroids (AAS)? Well. Exogenous * AAS, prohibited. 1. Anabolic androgenic steroids (AAS)? Well. Exogenous * AAS,

includingincluding::

- androstenediol (5- androstenediol (5α- α- androsta -1- ene -3androsta -1- ene -3β, 17β- β, 17β- diol ), 1- diol ), 1- androstenedione (5androstenedione (5α- α- androsta -1- ene -3 ,17 -dione ) androsta -1- ene -3 ,17 -dione ) bolandiol ( 19 norandrostendiol ) bolasteron , boldenone bolandiol ( 19 norandrostendiol ) bolasteron , boldenone , boldion ( androsta -1 ,4- dien -3 ,17 -dione ), 4 - , boldion ( androsta -1 ,4- dien -3 ,17 -dione ), 4 - hidroksytestosteron (4,17 hidroksytestosteron (4,17 β- β- dihydroxy- androsta - 4-en dihydroxy- androsta - 4-en -3-one ); hestrynon , danazol (17-3-one ); hestrynon , danazol (17α- α- etynyl -17etynyl -17β- β- hidroksyandrosta -4 Eno - [2,3-d] isoxazole ) hidroksyandrosta -4 Eno - [2,3-d] isoxazole ) дегідрохлорметилтестостерон (4- дегідрохлорметилтестостерон (4- chloro -17chloro -17β- β- hydroxy -17hydroxy -17α- α- metylandrosta -1 ,4- dien -3-one ); metylandrosta -1 ,4- dien -3-one ); dezoksymetyltestosteron (17dezoksymetyltestosteron (17α- α- methyl -5methyl -5α- α- androsta -2- androsta -2- ene -17ene -17β- β- ol ); Drostanolone ; etylestrenol (19 -nor -17ol ); Drostanolone ; etylestrenol (19 -nor -17α- α- Pregna - 4-en -17- ol ) kalusteron ; kvinbolon ; Pregna - 4-en -17- ol ) kalusteron ; kvinbolon ; Clostebol ; mestanolon ; mesterolon ; metandienon Clostebol ; mestanolon ; mesterolon ; metandienon (17(17β- β- hydroxy -17hydroxy -17α- α- metylandrosta -1, 4 - dien -3-one ); metylandrosta -1, 4 - dien -3-one ); metandriol ; metasteron (2metandriol ; metasteron (2α, 17α- α, 17α- dimethyl -5dimethyl -5α- α- androstan- 3-one -17androstan- 3-one -17β- β- ol ); metenolone ; methyl -1- ol ); metenolone ; methyl -1- testosterone (17testosterone (17β- β- hydroxy -17hydroxy -17α- α- methyl -5methyl -5α- α- androsta -androsta -1 -en- 3-one ); metyldyenolon (171 -en- 3-one ); metyldyenolon (17β- β- hydroxy -17hydroxy -17α- α- metylestra -4 ,9- dien -3-one ); metylnortestosteron metylestra -4 ,9- dien -3-one ); metylnortestosteron (17(17β- β- hydroxy -17hydroxy -17α- α- metylestra - 4-en -3-one ); metylestra - 4-en -3-one ); methyltestosterone ; metribolon ( metyltrienolon , 17methyltestosterone ; metribolon ( metyltrienolon , 17β- β- hydroxy -17hydroxy -17α- α- metylestra -4 ,9,11 - trien -3-onemetylestra -4 ,9,11 - trien -3-one

miboleron, nandrolone, norboleton; norklostebol; miboleron, nandrolone, norboleton; norklostebol; norethandrolone, 19 norandrostenedion norethandrolone, 19 norandrostenedion (estrogen-4-ene-3,17-dione) oksabolon, (estrogen-4-ene-3,17-dione) oksabolon, oxandrolone, oksimesteron, oxymetholone, oxandrolone, oksimesteron, oxymetholone, prostanozol (17prostanozol (17β-β-hydroxy-5hydroxy-5α-α-androstan [3,2-androstan [3,2-c ] pyrazole), stanozolol, stenbolon; c ] pyrazole), stanozolol, stenbolon; tetrahidrohestrynon (18tetrahidrohestrynon (18α-α-homo-Pregna-homo-Pregna-4,9,11-trien-174,9,11-trien-17β-β-ol-3-one), 1-testosterone ol-3-one), 1-testosterone (17(17β-β-hydroxy-5hydroxy-5α-α-androsta-1-ene-3 -one);androsta-1-ene-3 -one);

State of healthAthlete or Athlete

                                                                           Atsyklich                    Physical development or exercise                                           Features

Aerobic Exercise

Definition of indications and contraindications for study

Selection of appropriate forms of physical training

anaerobe anaerobe

                  no exercise no exercise

                Cycle Cycle exerciseexercise

DOSAGE EXERCISE

For capacity-tions

For metabolic lichnymy identical-nytsyamy

For the energy costs

According to the number repetitions

According to well-being

Recommendations athlete or sportsman

Dosage physical activity

For energy costs

For heart rate